Efficacy and safety of a sodium‐glucose co‐transporter‐2 inhibitor vs placebo as an add‐on therapy for people with type 2 diabetes inadequately treated with metformin and a dipeptidyl peptidase‐4 inhibitor: a systematic review and meta‐analysis of randomised controlled trials
2016 ◽
Vol 116
◽
pp. 86-95
◽
2017 ◽
Vol 72
(3)
◽
pp. 311-325
◽